Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ·Healthcare·Biotechnology
$2.39
+0.63%
Mkt Cap $152.65M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+193.5%
Consensus $7.00 vs current $2.39
NASDAQ·Healthcare·Biotechnology
$2.39
+0.63%
Mkt Cap $152.65M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
+193.5%
Consensus $7.00 vs current $2.39